Pfizer to Sell Capsugel to KKR
- Details
- Category: Pfizer
![Pfizer Pfizer](/images/stories/logo/pfizer_b.gif)
Boehringer Ingelheim's lead hepatitis C compound moves into phase III
- Details
- Category: Boehringer Ingelheim
![Boehringer Ingelheim Boehringer Ingelheim](/images/stories/logo/boehringeringelheim.gif)
GSK publishes payments for research, consulting and advising by US healthcare professionals
- Details
- Category: GlaxoSmithKline
![GlaxoSmithKline GlaxoSmithKline](/images/stories/logo/gsk.gif)
Pfizer Posts Details Of Interactions With U.S. Health Care Professionals And Researchers In 2010
- Details
- Category: Pfizer
![Pfizer Pfizer](/images/stories/logo/pfizer_b.gif)
REACT study to evaluate impact of Daxas® (roflumilast) in patients receiving standard COPD treatment
- Details
- Category: Nycomed
![Nycomed Nycomed](/images/stories/logo/nycomed.gif)
Sanofi-aventis Announces Registration Statement for CVR Related to Genzyme Acquisition Declared Effective
- Details
- Category: Sanofi
![sanofi-aventis sanofi-aventis](/images/stories/logo/sanofi-aventis.gif)
A new pharmaceutical candidate enters Lundbeck's development pipeline
- Details
- Category: Lundbeck
![Lundbeck Lundbeck](/images/stories/logo/lundbeck.gif)
More Pharma News ...
- Merck and Its Employees to Donate to Japanese Relief Effort
- UK and US governments reach agreement over AstraZeneca tax matters
- GSK statement on Avodart™ (dutasteride) for prostate cancer risk reduction
- Novartis completes acquisition of majority stake in Zhejiang Tianyuan expanding vaccines presence in China
- Sanofi-aventis Strengthens Commitment to Ophthalmology through Partnership with The Vision Institute
- SPIRIVA HandiHaler Prolonged Time To First COPD Exacerbation
- Roche announces positive pivotal Phase II results for Hedgehog Pathway Inhibitor